Compare Edwards Lifesciences Corporation Common Stock (EW) vs Plby Group Inc (PLBY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Plby Group Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B), while Plby Group Inc trades at $1 (market cap $118.21M). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 410.8× Plby Group Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Plby Group Inc nearer its low. Which is the better fit depends on your goals.
| EW | PLBY | |
|---|---|---|
Market Cap | $48.56B | $118.21M |
Volume | 6,520,488 | 919,783 |
Sector | Health | Consumer Cyclical |
52-Week High | $95.18 | $2.71 |
52-Week Low | $72.65 | $0.99 |
Enterprise Value | $45.01B | $263.80M |
Typical Hold Time | — | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PLBY Group trades at $1.02, down 1.92% on the day, with a bearish technical signal from moving averages. The company shows improving fundamentals with revenue stabilizing around $120-125 million and net losses narrowing significantly from -$278 million in 2022 to -$13 million in 2025. Recent management appointments aim to drive brand growth, while positive operating cash flow in 2025 and projected profitability in 2026 signal potential turnaround.
While analyst consensus remains strongly bullish (75% buy ratings), the stock faces headwinds from high debt levels and negative shareholder equity. The path to sustainable profitability remains the key catalyst, with current valuation metrics suggesting cautious optimism if execution improves. Near-term price action appears range-bound near support levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Plby Group Inc
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →
